Invention Grant
- Patent Title: Use of aminoglycoside analogs in the treatment of Rett syndrome
-
Application No.: US16258735Application Date: 2019-01-28
-
Publication No.: US10576095B2Publication Date: 2020-03-03
- Inventor: Timor Baasov , Shmuel Tuvia , Dori Pelled
- Applicant: Eloxx Pharmaceuticals Ltd.
- Applicant Address: IL Rehovot
- Assignee: ELOXX PHARMACEUTICALS LTD.
- Current Assignee: ELOXX PHARMACEUTICALS LTD.
- Current Assignee Address: IL Rehovot
- Agency: Perkins Coie LLP
- Agent Patrick D. Morris
- Main IPC: A61K31/7036
- IPC: A61K31/7036

Abstract:
Compounds, methods and uses of pseudo-trisaccharide aminoglycosides represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification, in the treatment of Rett syndrome are disclosed.
Public/Granted literature
- US20190183915A1 USE OF AMINOGLYCOSIDE ANALOGS IN THE TREATMENT OF RETT SYNDROME Public/Granted day:2019-06-20
Information query
IPC分类: